Learn details of the Reporting and evaluation of recent industry developments
Global Hyperuricemia Market: Overview
Hyperuricemia is condition in which the level of uric acid in the blood increases to abnormally high levels. Various factors are responsible for hyperuricemia, which include insulin resistance, renal failure, obesity and alcohol consumption which is found to be the most prevalent factor.
Scientists are still trying to confirm obesity as a predisposing factor for hyperuricemia,
According to data published in National Institute on Alcohol Abuse and Alcoholism, U.S. an average of 17 million U.S. citizens suffered from alcohol use disorder in 2011.
Approximately 70% of the uric acid produced in the body is filtered by the kidneys, while the remaining amount is eliminated by intestine. In individuals suffering from renal failure, the elimination of uric acid by the kidney decreases, leading to increased uric acid levels in blood.
Further, an article published in the Journal of the America College of Cardiology in the year 2012 suggests that hyperuricemia is found to be associated with dyslipidemia of insulin resistance, systemic inflammation, and hepatic steatosis independent of obesity and metabolic syndrome. Another article published in the journal Arthritis Care & Research in 2013 also suggests further confirmation of obesity as a factor leading to hyperuricemia.
Obtain Report Details: www.transparencymarketresearch.com…cemia-market.html
However pre diabetes and insulin resistance are found to be one of the factors leading to hyperuricemia. Articles published in Current Opinion in Rheumatology and BMC Cardiovascular Disorders published in 2013 and 2012 have confirmed the factors.
Global Hyperuricemia Market: Trends and Prospects
Various drugs especially cancer drugs are also found to cause hyperuricemia. High level of uric acid in the blood for a prolonged period of time is also a major cause of gout.
These factors will increase the prevalence of hyperuricemia as drive the market in the future. Currently ULORIC (febuxostat) manufactured by Takeda Pharmaceuticals is widely prescribed for treating hyperuricemia.
However the drug is not prescribed for treatment of high uric acid without a history of gout.
Various clinical trials are carried out by research institutes and companies in order to discover most efficient drug for rearming the disorder. Ardea Biosciences, Inc. is conducting phase 2 clinical trials for testing efficiency of RDEA806 for treatment of hyperuricemia.
Hebei Medical University is conducting phase 3 trials to test the hypothesis that prednisone is superior over allopurinol in renal function improvement in heart failure patients with hyperuricemia. TWi Biotechnology, Inc. was awarded with U.S.
patent in 2014 for AC – 201 which is effective in treating hyperuricemia. Similar research and development activities will add more products to the market and expand its reach globally.
Lesser competition and wide scope for research and development activities have made the market more attractive. As newer drugs receive regulatory approvals, the market is expected to boost in the near future.
Due to high cost of branded drugs, the market will have a restricted growth in the regions of Asia Pacific, Latin America, the Middle East and Africa which majorly comprise of under developed and developing economies.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size.
The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Category: Market Research Publishers and RetailersCompany profile: TMR provides a range of marketing and business research solutions designed for your specific needs. From off-the-shelf syndicated business And market research to made-to-order custom research, we serve our clients to fulfill their immediate as well as ongoing research requirements. We specialize in the following areas: Syndicated Research Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverage ...
For more information:Make an Inquiry about this report HERE!